StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
Humana (HUM) Reiterated at Neutral by Cantor Fitzgerald on $30B RFP Medicaid Award
June 11, 2026 7:08 AM
Cantor Fitzgerald analyst Sarah James reiterated a Neutral rating and $100.00 price target on Humana (NYSE: HUM).The analyst commented, "IL ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
Analyst Comments
